Want to learn more about North Carolina’s efforts to boost the state’s biotechnology industry?

Need to get more information about the new Hatteras BioCaptial fund, set up in part with a $30 investment made by the Golden Leaf Foundation?

Interested in the challenges and opportunities facing the biotech sector, from drug development to going public?

Those topics and more will be discussed at the 13th annual Biotechnology Conference, which is sponsored by the NC Biotechnology Center, the Council for Entrepreneurial Development, NCBIO and the BIO organization, on Wednesday and Thursday.

More than 800 people are expected to attend the two-day event at the Sheraton Imperial Hotel.

Dr. Leroy Hood, president of the Institute for Systems Biology, opens the program this afternoon with a speech.

He will be followed by Steve Burrill, chief executive officer and founder of Burrill & Company.

Dr. Ralph Snyderman, chancellor, Health Affairs, Duke University and president and CEO, Duke University Health System, will deliver the luncheon speech on Thursday,

Thursday’s program includes several panel discussions.

The first panel, “Trading Spaces, NASDAQ Style – Makeover from Private to Public Company,” will be moderated by Michael Recny, vice president of corporate development, at Trimeris. Panelists include:

  • Charles Baltic, Managing Director, Healthcare Investment Banking, Wachovia Securities

  • Eric Schmidt, Managing Director, SG Cowen

  • Christy Shaffer, Ph.D., CEO, Inspire Pharmaceuticals

  • Marshall Smith, Executive Director, Morgan Stanley
  • Other panel sessions include:

    “Prescription Drug Benefits: The Payor’s Impact on Small Companies and Their Investors”:

  • Clay Thorp, general partner, Hatteras BioCapital, moderator

  • Maren Anderson, Founder, MDA Consulting

  • Greg Mossinghoff, President, Inspire Pharmaceuticals, Inc.

  • Amir Nashat, Principal, Polaris Venture Partners
  • “University-Led Economic Development Initiatives: Promoting Growth in North Carolina and Throughout the Southeast”:

  • James Milliken, Senior Vice President for University Affairs, University of North Carolina, moderator

  • Bill Dean, President, !dealliance

  • Mark Lanier, Special Assistant to the Chancellor, University of
    North Carolina at Wilmington

  • Catherine Renault, Ph. D., Program Manager, RTI, International & Southeast Technology Expo

  • Bradford B. Walters, MD, PhD, MBA, Partner, Academy Funds
  • “Paths for Commercializing New Ideas”:

  • Garheng Kong, M.D., Ph.D., Partner, Intersouth Partners, moderator

  • John Didsbury, Ph.D., President and CEO, Nuada Pharmaceuticals, Inc.

  • Richard Kouri, Ph.D., President and CEO, Nanolytics, Inc. and Entrepreneur-in-Residence, Kenan-Flagler Business School, UNC-CH

  • Charles Scarantino, M.D., Ph.D., Founder and Medical Director, Sicel Technologies, Inc.
  • “North Carolina’s Biomanufacturing & Pharmaceutical Training Consortium: Establishing a World-Class Workforce”:

  • Michael Crossin, Ph.D., International Business Development Manager, North Carolina Department of Commerce, moderator

  • Ken Harewood, Ph.D., Professor of Biology and Director, Biomedical/Biotechnology Research Institute, North Carolina Central University

  • Peter K. Kilpatrick, Ph.D., Head, Department of Chemical Engineering, NC State University

  • Susan Seymour, Regional Customized Training Director for the Research Triangle Economic Development Region, North Carolina Community College System

  • Samuel Taylor, Executive Vice President, North Carolina Biosciences Organization
  • For more information, visit: www.cednc.org